Results 191 to 200 of about 1,142,563 (307)

Emulating a Randomized Controlled Trial of Long‐Acting Insulins and Cardiovascular Events Using Real‐World Data for Patients With Type 2 Diabetes

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Aims Randomized controlled trials (RCTs) have high internal validity but often have limited generalizability. To our knowledge, there have been no previous studies emulating RCTs using real‐world data to evaluate the risk of major adverse cardiovascular events (MACE) among patients with type 2 diabetes mellitus (T2DM) treated with long‐acting ...
Wanning Wang   +5 more
wiley   +1 more source

A novel delta opioid receptor specific peptide reduces craving in an animal model of cocaine seeking

open access: gold
Pnina Shirel Itzhak-Israeli   +13 more
openalex   +1 more source

Cyclic Opioid Peptide Agonists and Antagonists Obtained Via Ring‐Closing Metathesis

open access: yesChemical Biology and Drug Design, 2009
I. Berezowska   +4 more
semanticscholar   +1 more source

Glucagon‐like peptide‐1 receptor agonist and respiratory complications after endoscopy: A Japanese nationwide cohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 316-323, January 2026.
Abstract Aims While discontinuation of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) before esophagogastroduodenoscopy (EGD) is not universally mandated, safety concerns persist. Evidence remains insufficient for managing specific patient subgroups, particularly in Asian populations. We aimed to provide evidence for stratified risk assessment in
Hiroyuki Hisada   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy